← Back to Search

Meal Replacement

Meal replacement shake for Type 2 Diabetes

N/A
Waitlist Available
Led By Susanne Mitschke, MSc
Research Sponsored by Teatis, Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Study Summary

This trial will study how well a meal-replacement shake helps people with type 2 diabetes and if it improves their quality of life.

Eligible Conditions
  • Type 2 Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Improvement of quality of life score from baseline to 12-weeks
Secondary outcome measures
High Density Lipoprotein Cholesterol
Improvement in LDL cholesterol levels from baseline to 12-weeks
Improvement in a1c levels from baseline to 12-weeks
+4 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Meal replacement shakeExperimental Treatment1 Intervention
Teatis meal replacement shake
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Meal replacement shake
2017
N/A
~30

Find a Location

Who is running the clinical trial?

CitruslabsIndustry Sponsor
68 Previous Clinical Trials
3,745 Total Patients Enrolled
Teatis, IncLead Sponsor
Susanne Mitschke, MScPrincipal InvestigatorCitruslabs
3 Previous Clinical Trials
135 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is my profile compatible with the requirements of this medical experiment?

"This medical trial is recruiting 100 individuals, aged eighteen to seventy-five, who have been diagnosed with type two diabetes mellitus. Additional requirements for potential participants include: gender (male or female), body mass index between 27 and 40 kg/m2 , no existing health issues beyond the scope of the screening questionnaire, possession of a glucometer in their residence, and ongoing use of any medication with a stable dose for 90 days prior to entry."

Answered by AI

Are older individuals being accepted for inclusion in this research project?

"This medical study is open to participants that are 18 years of age or older but no more than 75."

Answered by AI

Are there currently opportunities to enroll in this clinical trial?

"Data found on clinicaltrials.gov displays that this particular medical trial, which was initially listed on September 15th 2022 and recently updated April 25th 2022, is no longer recruiting patients. Nonetheless, there are presently 1391 other trials actively seeking participants at the present time."

Answered by AI
~39 spots leftby Apr 2025